Fabtech Technologies, a biopharma engineering solutions provider, launched its Rs 230 crore IPO on September 29, closing October 1, with a price band of Rs 181-191. The issue is attracting strong grey market interest, indicating an 18% listing gain expectation. Proceeds will fund working capital and acquisitions, bolstering its robust financial performance and diversified order book.
​Fabtech Technologies, a biopharma engineering solutions provider, launched its Rs 230 crore IPO on September 29, closing October 1, with a price band of Rs 181-191. The issue is attracting strong grey market interest, indicating an 18% listing gain expectation. Proceeds will fund working capital and acquisitions, bolstering its robust financial performance and diversified order book. by Soban News (international And National News)
